Assignee
HARBIN ZHENBAO PHARMACEUTICAL CO LTD
CN·3 granted patents·1 citations·filing 2017–2018
Top patents by PatentIndex Score
3 records- 0171US10654868B2Dihydropyrazole azepine compound serving as Akt inhibitorHARBIN ZHENBAO PHARMACEUTICAL CO LTD·Filed 2017·Granted May 19, 2020·1 cites·12 claims
- 0248US11261196B2Salt serving as AKT inhibitor and crystal thereofHARBIN ZHENBAO PHARMACEUTICAL CO LTD·Filed 2018·Granted Mar 1, 2022·0 cites·20 claims
- 0346US11078194B2Salt form and crystal form serving as FGFR and VEGFR inhibitor compounds, and preparation method thereforHARBIN ZHENBAO PHARMACEUTICAL CO LTD·Filed 2018·Granted Aug 3, 2021·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when HARBIN ZHENBAO PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →